Deninta 60 Mg Injection - Physical Form: Liquid

7500 INR (Approx.)

4300 INR (Approx.)

124225 INR (Approx.)

India

India

Liquid

Liquid

sterile, lyophilized powder

Adults

Adults

10 Per Day

25 Per Week

100 Per Day

Take Exactly as Directed by A Doctor or As Mentioned on The Label; Dosage May Vary Based on Age, Weight, and Medical Condition

Dosage Guidelines Administration: Subcutaneous injection (not IV or IM). Starting dose (adults): -thalassemia: 1 mg/kg once every 3 weeks. Myelodysplastic syndromes (MDS): 1 mg/kg once every 3 weeks. Adjustment: If response is inadequate, dose may be increased to 1.25 mg/kg (maximum). Dose interruptions or reductions may be required for side effects (e.g., high hemoglobin, hypertension, bone pain). Treatment goal: Reduce or eliminate the need for red blood cell transfusions. Reconstitution: Each vial must be reconstituted with sterile water before injection

As per the Industrial Standard

Packaging DetailsForm: Lyophilized powder for solution (white to off-white).Strengths available:25 mg/vial75 mg/vialContainer: Type I clear glass vial with a rubber stopper and flip-off aluminum seal.Presentation: Each carton contains 1 single-dose vial.Labeling: Vial label and outer carton show drug name (Reblozyl / Luspatercept-aamt), strength, batch/lot number, expiry date, and storage conditions.Reconstitution: Supplied without diluent; requires Sterile Water for Injection (provided separately by healthcare facility).Storage: Refrigerated at 2 C to 8 C, protected from light.